Japanese Encephalitis Vaccine

Kathryn Dzintars, Pharm.D. BCPS, Noreen A. Hynes, M.D., M.P.H., D.T.M.&H.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.
Japanese Encephalitis Vaccine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

  1. Inactivated SA-14 virus strain: grown in Vero cells (IXIARO).
    1. The only licensed vaccine in the U.S. Indicated in the U.S. for all persons > 2 months of age.
    2. The same vaccine is sold in other countries as JESPECT.
  2. In some other countries, a live, attenuated SA-14 strain vaccine is available.
  3. The previously available (Biken) vaccine grown in mouse-brain is only available in Japan.

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

  1. Inactivated SA-14 virus strain: grown in Vero cells (IXIARO).
    1. The only licensed vaccine in the U.S. Indicated in the U.S. for all persons > 2 months of age.
    2. The same vaccine is sold in other countries as JESPECT.
  2. In some other countries, a live, attenuated SA-14 strain vaccine is available.
  3. The previously available (Biken) vaccine grown in mouse-brain is only available in Japan.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: July 3, 2020